NERV

Minerva Neurosciences Stock Analysis

AI Rating

Neutral
  • Quality2/10
  • Growth↓ 2/10
  • Value↓ 4/10
Minerva Neurosciences sales and earnings growth
NERV Growth
Fair
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↓ -18347.37%
  • FCF Y/Y↑ 30.89%
Minerva Neurosciences gross and profit margin trends
NERV Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↓ -61.22%
Minerva Neurosciences net debt vs free cash flow
NERV Risk
Great
  • Debt / Equity↑ 999.0
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 999.0

Minerva Neurosciences stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗